Prismocitrate 18

DRUG2 trials

Sponsors

Vantive Health LLC

Conditions

Acute Kidney InjuryAcute Kidney Injury (AKI)Continuous Renal Replacement Therapy (CRRT)Regional Citrate Anticoagulation (RCA)

Phase 3

Clinical Evaluation of Use of Prismocitrate 18 in Patients Undergoing Acute Continuous Renal Replacement Therapy (CRRT)

TerminatedNCT02860130

Vantive Health LLCAcute Kidney Injury, Continuous Renal Replacement Therapy (CRRT), Regional Citrate Anticoagulation (RCA)

Start: 2016-09-27End: 2018-05-12Updated: 2025-07-22

Safety Evaluation of Prismocitrate 18 in Patients Receiving CRRT

RecruitingNCT05399537

Vantive Health LLCAcute Kidney Injury (AKI), Continuous Renal Replacement Therapy (CRRT), Regional Citrate Anticoagulation (RCA)

Start: 2024-07-12End: 2026-12-01Target: 40Updated: 2026-07-27